Detalhe da pesquisa
1.
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa.
Acta Haematol;
146(2): 95-105, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35977532
2.
Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
J Antimicrob Chemother;
77(11): 3138-3143, 2022 10 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36101479
3.
Tanzania's position on the COVID-19 pandemic.
Lancet;
397(10284): 1542-1543, 2021 04 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33864748
4.
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.
Lancet Haematol;
10(4): e261-e271, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36870358
5.
Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania.
Front Med (Lausanne);
9: 1034682, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36687433
6.
Risk factors for anaemia among HIV infected children attending HIV care and treatment clinic at Muhimbili National Hospital in Dar es Salaam, Tanzania.
Tanzan J Health Res;
14(1): 68-74, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26591749
7.
Audit of clinical-laboratory practices in haematology and blood transfusion at Muhimbili National Hospital in Tanzania.
Tanzan J Health Res;
14(4): 257-62, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26591723